{"id":"NCT00280059","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy","officialTitle":"A Randomized, Comparative, Double-Blind, Parallel-Group, Multicenter, Monotherapy, Study Of Pregabalin (Lyrica) And Lamotrigine (Lamictal) In Patients With Newly Diagnosed Partial Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-08","primaryCompletion":"2009-12","completion":"2010-04","firstPosted":"2006-01-20","resultsPosted":"2011-10-24","lastUpdate":"2021-01-28"},"enrollment":660,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy, Partial"],"interventions":[{"type":"DRUG","name":"Pregabalin","otherNames":[]},{"type":"DRUG","name":"Lamotrigine","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess whether Lyrica is a safe and effective treatment for partial epilepsy in comparison with an established treatment, Lamictal.","primaryOutcome":{"measure":"Percentage of Seizure-free Participants (Responders) During Efficacy Assessment Phase","timeFrame":"Week 5 up to Week 56","effectByArm":[{"arm":"Pregabalin","deltaMin":51.6,"sd":null},{"arm":"Lamotrigine","deltaMin":67.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":102,"countries":["Belgium","Bulgaria","China","Colombia","Czechia","Estonia","Finland","France","Germany","Hong Kong","Hungary","India","Ireland","Italy","Latvia","Lithuania","Mexico","Netherlands","Norway","Portugal","Romania","Singapore","Slovakia","South Korea","Spain","Sweden","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["21889410"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081046&StudyName=Study%20Of%20The%20Safety%20And%20Efficacy%20Of%20Lyrica%20In%20The%20Treatment%20Of%20Newly%20Diagnosed%20Partial%20Epilepsy"]},"adverseEventsSummary":{"seriousAny":{"events":44,"n":330},"commonTop":["Headache","Dizziness","Fatigue","Somnolence","Upper respiratory tract infection"]}}